Blogs

Corporate Governance: In the News - Articles of Interest

• U.K. Parliament Votes to Delay Brexit as Turmoil Drags On - WSJ, March 15, 2019
• SEC Charges Volkswagen With Defrauding U.S. Bond Investors - WSJ, March 15, 2019
• Study Shows 'Disheartening' Lack of Diversity at Legal Departments, Law Firms | Corporate Counsel, March 15, 2019
• Activist Seeks Seat on Marriott’s Board - WSJ, March 15, 2019
• Half of Insider-Trading Defendants Net Less Than $60,000 - WSJ, March 15, 2019
• Amazon HQ2 Runs Into Community Activists in Virginia, Too - WSJ, March 15, 2019
• Experts Say When General Counsel Leaves Abruptly, Board Has Duty to Ask Why | Corporate Counsel, March 15, 2019
• SEC Reg BI's Economic Analysis Too Weak, Will Face Legal Challenges: SEC's Jackson | ThinkAdvisor, March 14, 2019
• In-House Counsel in Construction Industry May See Uptick in Anti-Corruption Enforcement | Corporate Counsel, March 14, 2019
• US activist shareholders push Amazon on everything from facial recognition to climate change - Tech News | The Star Online, March 14, 2019
• MPs back Brexit delay as votes lay bare cabinet divisions | Politics | The Guardian, March 14, 2019
• Senate proposal would give SEC more tools to seek restitution for investors - Pensions & Investments, March 14, 2019
• Here’s how the SEC should decide if companies should report earnings only every 6 months - MarketWatch, March 14, 2019
• House Dem introduces bill requiring public firms to disclose cybersecurity expertise in leadership | TheHill, March 13, 2019
• MPs overwhelmingly back Brexit delay | Reuters, March 13, 2019
• SEC chair Clayton on Elon Musk saga: 280 characters on Twitter ‘just aren’t enough’ at times | Fox Business, March 13, 2019
• Scoop: Oil producer EOG Resources commits to methane target - Axios, March 11, 2019
• SEC’s Clayton: Plan for volatile markets if there’s a hard Brexit - MarketWatch, March 11, 2019
• Regulating ISS, Proxy Advisers Is on SEC’s Radar Under Roisman - Bloomberg, March 11, 2019
• Does Bristol-Myers have a plan B if activists scuttle its Celgene buy? | FiercePharma, March 11, 2019